Disease awareness campaign encourages men to overcome their embarrassment and openly discuss Peyronie's disease (PD), taking charge of their health.Campaign empowers men to connect with trusted ...
After Crinetics Pharmaceuticals announced topline results from an open-label, Phase 2 study of atumelnant, a once-daily oral adrenocorticotropic hormone receptor antagonist candid ...